Ron Laufer serves as Executive at CATABASIS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Ron Laufer has executed 3 insider transactions totaling $2.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 30, 2015 involved exercising options for 330,098 shares valued at $0.
Ron Laufer currently holds 1,409,213 shares of CATABASIS PHARMACEUTICALS INC (CATB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ron Laufer has been a net buyer of CATB stock. They have purchased $2.7M and sold $0 worth of shares.
Ron Laufer's most recent insider trade was on Jun 30, 2015, when they sold 330,098 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 30, 2015 | CATB | $2.7M | Purchase | 223,439 | $12.00 | Discretionary |